Steven D. Skolsky
Basilea Pharmaceutica Ltd
Steven D. Skolsky, US citizen, has served as a member of the Board of Directors since 2008 and from 2009-2010 served as Vice Chairman of the Board. From 2011 until August 2016, Mr. Skolsky served as a senior executive at Quintiles Transnational Holdings, most recently as Senior Vice President and Managing Director and previously, Head of Global Clinical Operations. From 2006 to 2011, Mr. Skolsky served as the Chief Executive Officer and President of Sequoia Pharmaceuticals Inc. and from 2004 to 2006 as Chief Executive Officer of Trimeris Inc. Mr. Skolsky joined Trimeris from GlaxoSmithKline (GSK), where he had served for more than 20 years in a range of senior leadership roles, including Senior Vice President, Global Product Strategy and Clinical Development, and Managing Director of GSK’s operations in Australia and New Zealand. Mr. Skolsky serves on the Foundation Board of the Kenan-Flagler School of Business at the University of North Carolina at Chapel Hill (USA). Mr. Skolsky holds a B.A. in Biology from the University of North Carolina at Chapel Hill.